Thalassaemia

By Dr. Venugopal Reddy
Medical Director, Pediatrician & Community Health Advocate 

Hospital name : Ovum Woman and Child Speciality Hospital, Bangalore

Every year on May 8th, the global community observes World Thalassemia Day, a day dedicated to raising awareness, advocating for the rights of patients, and promoting stronger policies around this inherited blood disorder. The theme for 2025, “Together for Thalassaemia: Uniting Communities, Prioritizing Patients,” along with the powerful slogans #WeAre1 and #PatientsFirst, offers a timely reminder that collective effort and patient-centered care are essential to confronting the global burden of thalassemia.


Understanding Thalassemia

Thalassemia is a group of inherited blood disorders caused by mutations in the genes responsible for hemoglobin production. Hemoglobin is the oxygen-carrying component of red blood cells. In thalassemia, the body produces abnormal hemoglobin, leading to the destruction of red blood cells and resulting in anemia, fatigue, bone deformities, growth delays, and in severe cases, life-threatening complications.

There are different types of thalassemia — alpha and beta thalassemia being the most common — and their severity can range from silent carriers to thalassemia major, which often requires regular blood transfusions and iron chelation therapy throughout life.

Thalassemia is particularly prevalent in parts of India, Southeast Asia, the Mediterranean, and the Middle East, affecting millions of people either as carriers or patients.


Why This Year’s Theme Matters

The 2025 theme emphasizes two essential pillars in the fight against this disorder:

1. Unity Across Communities: Tackling thalassemia requires collective involvement from families, healthcare providers, researchers, policymakers, NGOs, and the public. By bridging geographical, cultural, and social divides, we can create a stronger support system for patients and improve prevention, early diagnosis, and care.

2. Prioritizing Patients: The heart of thalassemia advocacy must always be the patient. This includes ensuring timely diagnosis, availability of safe and adequate blood, access to chelation therapy, psychosocial support, and inclusion in decision-making processes. Health systems must be reoriented to become more responsive and empathetic to the lifelong needs of thalassemia warriors.

The hashtags #WeAre1 and #PatientsFirst reflect a global solidarity and reaffirm that thalassemia care should not be fragmented or discriminatory. Every patient, regardless of where they live or what resources they have, deserves dignity, compassion, and evidence-based care.


India and the Thalassemia Challenge

India bears a significant burden of thalassemia, with an estimated 10,000–12,000 children born with thalassemia major every year. Around 40 million Indians are silent carriers of the beta-thalassemia gene. Unfortunately, lack of awareness, inadequate screening, and social stigma often lead to delayed diagnosis and suboptimal treatment.

As a pediatrician and community health advocate, I have seen families struggling with repeated transfusions, rising treatment costs, and emotional trauma. Prevention is still our best weapon, and carrier screening programs, prenatal diagnosis, and genetic counseling must be scaled up, especially in high-risk populations.


What Needs to Change: From Awareness to Action

To truly live up to this year’s theme, we must move beyond token gestures and implement meaningful reforms across several domains:

1. Mandatory Premarital and Antenatal Screening
Genetic screening and counseling should be offered routinely to couples, especially in thalassemia-prevalent areas. This can help identify carrier couples early and offer them informed reproductive choices.

2. Improved Access to Quality Blood and Chelation
Many patients in rural areas struggle with access to safe and voluntary blood donations. Government and NGO-supported blood banks must be strengthened. At the same time, iron overload management through chelation therapy should be made universally accessible.

3. Bone Marrow Transplant and Gene Therapy Support
Curative therapies like hematopoietic stem cell transplantation and emerging gene-editing technologies should be made affordable and available. Public health systems must subsidize these options for eligible families.

4. Thalassemia Registries and Data Tracking
India must develop a national thalassemia registry to track cases, identify trends, and guide policy decisions. This will enable better forecasting of healthcare needs and resource allocation.

5. Education and Community Empowerment
Awareness campaigns should not be limited to medical circles. Schools, colleges, workplaces, and communities should be involved in creating awareness through education drives, storytelling, social media campaigns, and workshops.


The Role of Pediatricians and Primary Care Physicians

Early diagnosis and comprehensive care begin at the primary healthcare level. Pediatricians must play a proactive role in:

  • Recognizing early signs like persistent anemia, jaundice, or splenomegaly

  • Referring patients for appropriate diagnostic work-up including hemoglobin electrophoresis or genetic testing

  • Educating parents about transfusion protocols, iron monitoring, and growth milestones

  • Providing emotional and developmental support to children and families

In addition, pediatricians must become community champions for thalassemia awareness, pushing for screening and prevention programs in schools and urban slums.


Stories That Inspire

Behind every statistic is a story of resilience. Children and adults with thalassemia face countless medical appointments, school absences, and emotional battles. Yet, many go on to live full, meaningful lives—pursuing higher education, careers, and starting families.

Organizations led by patients and caregivers are now creating platforms where thalassemia voices are heard, policies are influenced, and myths are shattered. These stories inspire a new generation of activists, healthcare workers, and policymakers to take action.


Final Words: A Call to Unite

On this World Thalassemia Day 2025, let us go beyond sympathy. Let us act.

Let us unite as one global community, transcending boundaries, to support patients not just in hospitals, but in every sphere of life — at home, in schools, at workplaces, and in policy halls.

Let us reaffirm our commitment to a “Patients First” approach, where no child suffers because of a lack of blood, no youth misses dreams due to stigma, and no family is left helpless due to unaffordable care.

Let us say together, #WeAre1.

Together, we can build a world where thalassemia is no longer a burden—but a challenge we have learned to overcome with unity, innovation, and compassion.